Oricula Therapeutics Revenue

Seattle, Washington, United States • 1-10 Employees

Oricula Therapeutics revenue & valuation

Annual revenue	$2,000,000
Revenue per employee	$2,000,000
Estimated valuation?This valuation is estimated based on industry average for the current industry and current estimated revenues	$6,400,000
Total funding	No funding

Key Contact at Oricula Therapeutics

Vince Groppi

Chief Executive Officer

Company overview

Headquarters	474 39th Avenue East, Seattle, Washington 98112, US
Phone number	+12063227526
Website	oricularx.com
SIC	873
Employees	1-10
Socials

Oricula Therapeutics Email Formats

Oricula Therapeutics uses 1 email format. The most common is {last name} (e.g., doe@oricularx.com), used 100% of the time.

Format	Example	Percentage
{last name}	doe@oricularx.com	100%

About Oricula Therapeutics

Oricula Therapeutics is a company that develops the first medication to prevent drug-induced hearing loss. They aim to protect inner ear hair cells from damaging effects of drugs and aging.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

Oricula Therapeutics has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Oricula Therapeutics has never raised funding before.

Oricula Therapeutics Tech Stack

Discover the technologies and tools that power Oricula Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Adobe Fonts

Font scripts

Modernizr

JavaScript libraries

Lodash

JavaScript libraries

Google Workspace

Squarespace Commerce

Ecommerce

Google Hosted Libraries

CDN

jQuery

JavaScript libraries

reCAPTCHA

Security

HSTS

Security

Open Graph

Miscellaneous

core-js

JavaScript libraries

Frequently asked questions

Oricula Therapeutics is located in Seattle, Washington, US.

You can reach Oricula Therapeutics at +12063227526.

Oricula Therapeutics generates an estimated annual revenue of $2,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Oricula Therapeutics has an estimated valuation of $6,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Oricula Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Oricula Therapeutics

Vince Groppi

Chief Executive Officer

4.8

40,000 users